New drug applications approved by US FDA as of 1 - 15 November 2017 which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date.
The presence of corneal arcus in Indian and Malay men appears to be associated with the risk of incident cardiovascular disease (CVD), independent of serum lipids and traditional CVD risk factors, reports a team of Singapore-based researchers.
The presence of vitreous haze, snow banking, and choroidal involvement is associated with an increased risk of antitubercular treatment failure in patients with tubercular (TB) uveitis, according to research by the COTS-1* Study Group.
Subtracting the original retinal thickness from the combined choroid-retina thickness to calculate the mean choroidal thickness (CT) is an easier and reliable method compared with the manual segmentation of optical coherence tomography (OCT) B-scans, a recent Singapore study has shown.
Eyes with hydroxychloroquine (HCQ) retinopathy show a significant decrease in total choroidal and choriocapillaris-equivalent thickness, suggesting that choroid may be a possible site for HCQ toxicity, according to a study.
The measurements of preoperative laser flare are not reliable in discriminating those patients with rhegmatogenous retinal detachment (RRD) at high and low risk of acquiring postoperative proliferative vitreoretinopathy (PVR), a recent study has found.
The prevalence of retinal emboli among Singaporeans, while low, varies widely by ethnicity, and is also associated with cardiovascular risk factors and chronic kidney disease (CKD), according to results of the SEED* study.
Small retinal arterioles, larger retinal venules and retinopathy are all associated with higher chronic kidney disease (CKD) risk, especially in individuals with diabetes, a new population-based study from Singapore has shown.
The baseline inferior subfield retinal thickness may predict the frequency of treatment for diabetic macular oedema (DME) during the first year in eyes administered pro re nata (PRN) intravitreal ranibizumab (IVR) injections, a new study shows.